calendar
2,562 catalysts · 4,301 phase readout · 2,263 8k filing · 282 earnings · 172 phase 2 completion · 73 phase 1 completion · 71 drug shortage
next 91 dayslessmore
MonWedFri
2,562 catalysts · 4,301 phase readout · 2,263 8k filing · 282 earnings · 172 phase 2 completion · 73 phase 1 completion · 71 drug shortage
Items: 7.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 1.01, 8.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 5.02, 9.01
Items: 5.02, 9.01
Items: 1.02
Items: 8.01
Items: 8.01
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 5.02, 5.07, 9.01
Items: 7.01, 8.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 8.01
Items: 7.01, 9.01
Items: 1.01, 7.01, 8.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Anticipated earnings call for ACME UNITED CORP ($ACU).
Anticipated earnings call for Sanofi ($SNY).
Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections
Therapy area: Gastrointestinal, Infectious Disease, Oncology. Indication: Acral Lentiginous Melanoma, Adenocarcinoma Of The Gastroesophageal Junction, Adenoid Cystic Carcinoma (ACC), Adrenocortical Carcinoma (Adrenal Cortex Cancer), Anaplastic Thyroid Cancer, Bile Duct Cancer (Cholangiocarcinoma), Bladder Cancer, Breast Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Endometrial Cancer, Ependymoma, Epithelial Ovarian Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Ewing S
Items: 1.01, 7.01, 9.01
Items: 1.01, 9.01
Items: 3.01
Items: 5.02
Items: 8.01, 9.01
Items: 5.02, 9.01
Items: 1.01, 2.03, 9.01
Items: 5.02, 9.01
Items: 1.01, 3.01, 9.01
Items: 8.01, 9.01
Items: 5.02
Items: 5.02, 9.01
Items: 1.01, 8.01, 9.01
Items: 5.02
Items: 5.02
Items: 1.01, 2.01, 3.02, 9.01
Items: 9.01
Items: 5.07
Items: 1.01, 8.01, 9.01
Items: 1.01, 3.02, 9.01
Items: 1.01, 9.01
Items: 5.03, 9.01
Items: 1.01, 9.01
Items: 5.02, 9.01
Items: 2.03